A–243A→G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects

Clinical Report
A–243A→G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects

T. W. Boesgaard, S. I. Castella, G. Andersen, A. Albrechtsen, T. Sparso, K. Borch-Johnsen, T. Jorgensen, T. Hansen and O. Pedersen

Diabetic Medicine, 2007, 24(7), 702-706. DOI: 10.1111/j.1464-5491.2007.02110.x


Aims The glutamate decarboxylase gene (GAD2) encodes GAD65, an enzyme catalysing the production of the γ-aminobutyric acid (GABA) which interacts with neuropeptide Y to stimulate food intake. It has been suggested that in pancreatic islets, GABA serves as a functional regulator of pancreatic hormone release. Conflicting results have been reported concerning the potential impact of GAD2 variation on estimates of energy metabolism. The aim of this study was to elucidate potential associations between the GAD2−243A→G polymorphism and levels of body mass index (BMI) and estimates of glycaemia.

Methods Using high-throughput chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, the GAD2−243A→G (rs2236418) polymorphism was genotyped in a population-based sample (Inter99) of 5857 middle-aged, unrelated Danish White subjects.

Results The G-allele was associated with modestly lower BMI (P = 0.01). In a case–control study of obesity, the G-allele frequency in 2582 participants with BMI < 25 kg/m2 was 19.5% (18.4–20.6) compared with 17.1% (15.5–18.8) in 968 participants having BMI ≥ 30 kg/m2 (P = 0.03), odds ratio 0.9 (0.7–1.0). Of the 5857 subjects, GG carriers had lower fasting plasma glucose levels (mmol/l) [AA (n = 3859) 5.6 ± 0.8; AG (n = 1792) 5.5 ± 0.8; GG (n = 206) 5.5 ± 0.8, P = 0.008] and lower 30-min oral glucose tolerance test (OGTT)-related plasma glucose levels (AA 8.7 ± 1.9; AG 8.6 ± 1.9; GG 8.6 ± 2.0, P = 0.04), adjusted for sex, age and BMI. Analysing subjects who were both normoglycaemic and glucose tolerant (n = 4431) GG carriers still had lower fasting plasma glucose concentrations: AA (n = 2895) 5.3 ± 0.4; AG (n = 1383) 5.3 ± 0.4; GG (n = 153) 5.2 ± 0.4 (P = 9.10−5).

Conclusion The present study suggests that the GAD2−243A→G polymorphism in a population of middle-aged White people associates with a modest reduction in BMI and fasting and OGTT-related plasma glucose levels.

ASCI-ID: 109-95

View Fulltext

Similar Articles

Effect of RBP4 gene variants on circulating RBP4 concentration and Type 2 diabetes in a Chinese population

Diabetic Medicine, 2008, 25(1), 11-18. DOI: 10.1111/j.1464-5491.2007.02314.x

The association of genetic variants in Kruppel-like factor 11 and Type 2 diabetes in the Japanese population

Diabetic Medicine, 2008, 25(1), 19-26. DOI: 10.1111/j.1464-5491.2007.02315.x

Two susceptible diabetogenic variants near/in MTNR1B are associated with fasting plasma glucose in a Han Chinese cohort

Diabetic Medicine, 2010, 27(5), 598-602. DOI: 10.1111/j.1464-5491.2010.02975.x

Association and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of Sorbs from Germany

Diabetic Medicine, 2011, 28(11), 1373-1380. DOI: 10.1111/j.1464-5491.2011.03374.x

Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry

Diabetic Medicine, 2012, 29(6), 761-766. DOI: 10.1111/j.1464-5491.2011.03529.x

Trends of diabetes according to body mass index levels in Iran: results of the national Surveys of Risk Factors of Non-Communicable Diseases (1999-2007)

Diabetic Medicine, 2010, 27(11), 1233-1240. DOI: 10.1111/j.1464-5491.2010.03103.x

Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis

Diabetic Medicine, 2011, 28(1), 10-18. DOI: 10.1111/j.1464-5491.2010.03160.x

Body mass index and risk of all-cause and cardiovascular mortality in hospitalized elderly patients with diabetes mellitus

Diabetic Medicine, 2009, 26(3), 253-259. DOI: 10.1111/j.1464-5491.2009.02672.x

Pregravid body mass index as a predictor of gestational diabetes mellitus

Diabetic Medicine, 2009, 26(4), 334-338. DOI: 10.1111/j.1464-5491.2009.02695.x

An FTO variant is associated with Type 2 diabetes in South Asian populations after accounting for body mass index and waist circumference

Diabetic Medicine, 2011, 28(6), 673-680. DOI: 10.1111/j.1464-5491.2011.03257.x

The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals

Diabetic Medicine, 2008, 25(8), 902-908.

Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetes

Diabetic Medicine, 2007, 24(6), 650-655. DOI: 10.1111/j.1464-5491.2007.02132.x

The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities

Diabetic Medicine, 2007, 24(7), 707-713. DOI: 10.1111/j.1464-5491.2007.02140.x

The associations of apolipoprotein E and angiotensin-converting enzyme polymorphisms and cognitive function in Type 1 diabetes based on an 18-year follow-up of the DCCT cohort

Diabetic Medicine, 2010, 27(1), 15-22. DOI: 10.1111/j.1464-5491.2009.02885.x

Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5)

Diabetic Medicine, 2010, 27(6), 701-704. DOI: 10.1111/j.1464-5491.2010.02997.x

Prevalence and clinical characteristics of maternally inherited diabetes and deafness caused by the mt3243A > G mutation in young adult diabetic subjects in Sri Lanka

Diabetic Medicine, 2008, 25(3), 370-374. DOI: 10.1111/j.1464-5491.2007.02377.x

Lack of pancreatic body and tail in HNF1B mutation carriers

Diabetic Medicine, 2008, 25(7), 782-787. DOI: 10.1111/j.1464-5491.2008.02460.x

RD Lawrence Lecture 2009 Old genes, new tricks: learning about blood glucose regulation from naturally occurring genetic variation in humans

Diabetic Medicine, 2009, 26(11), 1083-1089. DOI: 10.1111/j.1464-5491.2009.02860.x

Association of the POU class 2 homeobox 1 gene (POU2F1) with susceptibility to Type 2 diabetes in Chinese populations

Diabetic Medicine, 2010, 27(12), 1443-1449. DOI: 10.1111/j.1464-5491.2010.03124.x

Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes

Diabetic Medicine, 2011, 28(6), 681-684. DOI: 10.1111/j.1464-5491.2011.03269.x

Association of a polymorphism of BTN2A1 with Type 2 diabetes mellitus in Japanese individuals

Diabetic Medicine, 2011, 28(11), 1381-1387. DOI: 10.1111/j.1464-5491.2011.03358.x

Mechanistic insights into insulin resistance in the genetic era

Diabetic Medicine, 2011, 28(12), 1476-1486. DOI: 10.1111/j.1464-5491.2011.03463.x

Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy

Diabetic Medicine, 2014, 31(3), 254-262. DOI: 10.1111/dme.12352

Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes

Diabetic Medicine, 2009, 26(4), 409-415. DOI: 10.1111/j.1464-5491.2009.02691.x

Dramatic improvement of glucose control after plasmapheresis and prednisone in a patient with Type 1 diabetes

Diabetic Medicine, 2009, 26(9), 951-952. DOI: 10.1111/j.1464-5491.2009.02776.x

Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin

Diabetic Medicine, 2009, 26(2), 128-133. DOI: 10.1111/j.1464-5491.2008.02646.x

Determinants of blood glucose and insulin in healthy 9-month-old term Danish infants; the SKOT cohort

Diabetic Medicine, 2010, 27(12), 1350-1357. DOI: 10.1111/j.1464-5491.2010.03134.x

The relationship between low vital capacity and impaired glucose metabolism in men

Diabetic Medicine, 2010, 27(12), 1460-1461. DOI: 10.1111/j.1464-5491.2010.03112.x

Diabetes, impaired fasting glucose and their relations to plasma pro-inflammatory cytokines: a population-based study in China

Diabetic Medicine, 2010, 27(12), 1461-1463. DOI: 10.1111/j.1464-5491.2010.03122.x

Prevalence of diabetes and impaired glucose regulation in Estonia

Diabetic Medicine, 2011, 28(4), 504-505. DOI: 10.1111/j.1464-5491.2010.03218.x

Association and evolutionary studies of the melatonin receptor 1B gene (MTNR1B) in the self-contained population of Sorbs from Germany

Diabetic Medicine, 2011, 28(11), 1373-1380. DOI: 10.1111/j.1464-5491.2011.03374.x

Self-monitoring of blood glucose in Type 2 diabetes: cross-sectional analyses in 1993, 1999 and 2009

Diabetic Medicine, 2012, 29(6), 792-795. DOI: 10.1111/j.1464-5491.2011.03567.x

Access to insulin pump therapy and continuous glucose monitoring - is it an even playing field?

Diabetic Medicine, 2012, 29(8), 971-971. DOI: 10.1111/j.1464-5491.2012.03734.x

Management of raised glucose, a clinical decision tool to reduce length of stay of patients with hyperglycaemia

Diabetic Medicine, 2013, 30(1), 81-87. DOI: 10.1111/dme.12006

Diet quality is prospectively associated with incident impaired fasting glucose in older adults

Diabetic Medicine, 2013, 30(5), 557-562. DOI: 10.1111/dme.12109

Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?

Diabetic Medicine, 2013, 30(8), 914-917. DOI: 10.1111/dme.12175

Impact of continuous glucose monitoring on diabetes management and marital relationships of adults with Type 1 diabetes and their spouses: a qualitative study

Diabetic Medicine, 2014, 31(1), 47-54. DOI: 10.1111/dme.12276

Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance

Diabetic Medicine, 2014, 31(1), 76-83. DOI: 10.1111/dme.12288

Evidence for continuous glucose monitoring: sufficient for reimbursement?

Diabetic Medicine, 2014, 31(2), 122-125. DOI: 10.1111/dme.12341

Elevated liver enzymes are related to progression to impaired glucose tolerance in Japanese men

Diabetic Medicine, 2014, 31(5), 552-558. DOI: 10.1111/dme.12345

Post-partum weight loss and glucose metabolism in women with gestational diabetes: the DEBI Study

Diabetic Medicine, 2014, 31(7), 862-867. DOI: 10.1111/dme.12425

Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial

Diabetic Medicine, 2014, 31(9), 1086-1092. DOI: 10.1111/dme.12512